Key Takeaways
- Cerebras (CBRS) shares declined over 3% Tuesday following Freedom Capital’s initiation of coverage with a Hold rating.
- First-quarter revenue surged 92% annually to $193.4 million, though gross margin projections concerned market participants.
- Management anticipates 2026 full-year core revenue between $855 million and $865 million, representing approximately 69% expansion.
- The firm secured a $20 billion long-term agreement with OpenAI alongside a strategic Amazon Web Services collaboration.
- Analyst consensus price target of $299.30 suggests potential 44% appreciation from present trading levels.
Shares of Cerebras Systems experienced a decline exceeding 3% during Tuesday’s session, trading substantially beneath its annual peak. The downturn followed Freedom Capital analyst Paul Meeks’ debut coverage of the artificial intelligence semiconductor manufacturer with a Hold recommendation and $209 target price.
The equity has experienced volatility throughout recent months. Following its Nasdaq listing on May 14 at $185 per share, the stock initially rallied before entering a sustained downtrend. Last week witnessed a brief decline beneath its initial public offering price.
Meeks acknowledged that Cerebras hadn’t captured his attention prior to the post-earnings retreat. The subsequent price correction shifted his perspective, although he continues to identify risks that market participants may have overlooked.
Earnings Results Analysis
Cerebras unveiled its inaugural quarterly results as a publicly-traded entity following market close on June 23. Revenue expanded 92% year-over-year to $193.4 million. The net loss contracted to $14 million compared with $23.9 million in the prior-year period.
Hardware sales increased 60% to $111.6 million. Cloud and additional service revenue jumped 167% to $79.8 million. These figures exceeded analyst projections.
Concerns emerged from the company’s gross margin outlook. Margins had widened from 42.1% in the year-ago quarter to 46.5% in Q1. However, Cerebras projected margins would compress to a range of 38% to 41% throughout the fiscal year.
Executives clarified that the organization opted to temporarily lease back systems from a current customer while expanding its proprietary data center infrastructure. The chief executive later indicated that investors misinterpreted the guidance, emphasizing the margin contraction stemmed from that singular strategic decision rather than fundamental business deterioration.
Strategic Positioning for CBRS
Cerebras manufactures large-scale, wafer-sized inference processors requiring specialized thermal management. Due to their dimensions, the organization exclusively distributes them as complete systems rather than individual components.
The enterprise has secured substantial partnerships. A $20 billion multi-year contract with OpenAI was finalized in December. Additionally, the company established an agreement with Amazon Web Services to integrate Amazon’s Trainium processor with Cerebras’ CS-3 platform within AWS infrastructure.
That AWS collaboration isn’t projected to generate substantial revenue contributions until 2027. Currently, Cerebras relies on its established hardware and cloud operations to achieve financial objectives.
For the second quarter, Cerebras anticipates revenue will increase 88% to $194 million. Annual core revenue guidance ranges between $855 million and $865 million, translating to roughly 69% year-over-year growth.
Meeks highlighted two primary business segments for Cerebras moving forward. The first involves distributing CS-3 platforms for accelerated AI inference capabilities. The second centers on collaborating with hyperscale providers to distribute inference workloads, utilizing competing GPUs for initial processing stages and Cerebras’ processors for the decoding phase.
He identifies greater long-term potential in that secondary business model. He also observed that the recent price decline has eliminated considerable investment risk that existed previously.
Neverthstanding, Meeks cautioned that the recent trough of $161 may not necessarily function as reliable support. He believes that should Cerebras achieve its objective of tripling revenue in 2027, the equity could experience significantly more appreciation than depreciation.
Prior to Meeks’ Hold assessment, Wall Street consensus on Cerebras stood as a unanimous Strong Buy across 10 covering analysts. The average target price of $299.30 represents 44% potential upside from current trading levels.
CBRS shares were changing hands near $214 as of Tuesday, retreating from a 52-week high of $386.34 while remaining above the 52-week low of $160.81.
Get 3 Free Stock Ebooks
Discover top-performing stocks in AI, Crypto, and Technology with expert analysis.
- Top 10 AI Stocks - Leading AI companies
- Top 10 Crypto Stocks - Blockchain leaders
- Top 10 Tech Stocks - Tech giants
